Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Filament Health Corp N.FH

Alternate Symbol(s):  FLHLF

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.


NEO:FH - Post by User

Post by CmMuskieon Aug 16, 2022 3:41pm
237 Views
Post# 34900305

Worth noting. Insiders own about 70% of the shares.

Worth noting. Insiders own about 70% of the shares.

Insider Transactions Reported - Last Two Years

Insider Transaction Type Value Date Shares

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition carried out privately at price 0.10 per share. Direct 96,215 Jul 13, 2022 962,154

KINESHANKO (THOMAS)
10% Security Holder of Issuer

Acquisition or disposition carried out privately at price 0.07 per share. Direct 153,300 Jun 17, 2022 2,100,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.26 per share. Direct 393 Nov 18, 2021 1,500

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.24 per share. Direct 726 Nov 18, 2021 3,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.27 per share. Direct 2,700 Nov 18, 2021 10,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.24 per share. Direct 2,420 Nov 18, 2021 10,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.27 per share. Direct 5,206 Nov 18, 2021 19,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.25 per share. Direct 1,270 Nov 18, 2021 5,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.25 per share. Direct 492 Nov 18, 2021 2,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.25 per share. Direct 8,125 Nov 18, 2021 32,500

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.25 per share. Direct 2,952 Nov 18, 2021 12,000

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.30 per share. Direct 150 Aug 27, 2021 500

LIGHTBURN (BENJAMIN)
Director of Issuer

Acquisition or disposition in the public market at price 0.31 per share. Direct 463 Aug 27, 2021 1,500

<< Previous
Bullboard Posts
Next >>